- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
COVID-19 Vaccination May Alleviate long COVID Symptoms
A prospective observational cohort study published in International Journal Of Infectious Diseases by Maryam N and colleagues has shed light on the impact of COVID-19 vaccination on individuals experiencing post-COVID-19 conditions (PCC) or long COVID. The research aimed to understand how vaccination affected the evolution of symptoms, immune responses, and viral persistence in these patients.
● Following COVID-19 vaccination, there was a notable decrease in the number of PCC symptoms. The average number of symptoms dropped from 6.56 before vaccination to 3.92 after vaccination (p<0.001).
● Vaccination also led to a reduction in the number of affected organ systems in PCC patients. Prior to vaccination, individuals experienced an average of 3.19 affected organ systems, which decreased to 1.89 after vaccination (p<0.001).
● PCC patients reported improved psychological well-being after receiving the COVID-19 vaccine. Scores on the WHO-5 Well-Being Index increased from an average of 42.67 before vaccination to 56.15 after vaccination (p<0.001).
● COVID-19 vaccination resulted in decreased levels of several pro-inflammatory plasma cytokines and chemokines in PCC patients. These included sCD40L, GRO-⍺, macrophage inflammatory protein (MIP)-1⍺, interleukin (IL)-12p40, G-colony stimulating factor (CSF), M-CSF, IL-1β, and stem cell factor (SCF), indicating a reduction in systemic inflammation.
● PCC patients exhibited a certain level of immune reactivity to SARS-CoV-2, which was further boosted by vaccination. This suggests that vaccination enhances the immune response in individuals with PCC.
● SARS-CoV-2 S1 antigen persisted in the blood of PCC patients, particularly within non-classical monocytes. This phenomenon was observed irrespective of whether individuals had received vaccination.
These findings indicate that COVID-19 vaccination may have a positive impact on individuals experiencing PCC by reducing symptoms and systemic inflammation. However, the study also highlights the persistence of viral products in some patients, which could potentially contribute to ongoing inflammation through non-classical monocytes.
While this research provides valuable insights into the potential benefits of vaccination for those with PCC, further studies are needed to confirm these observations and better understand the underlying mechanisms.
Reference:
Nayyerabadi, M., Fourcade, L., Joshi, S. A., Chandrasekaran, P., Chakravarti, A., Massé, C., Paul, M.-L., Houle, J., Boubekeur, A. M., DuSablon, C., Boudreau, V., Bovan, D., Darbinian, E., Coleman, E. A., Vinci, S., Routy, J.-P., Hétu, P.-O., Poudrier, J., & Falcone, E. L. (2023). Vaccination after developing long COVID: impact on clinical presentation, viral persistence and immune responses. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases.https://doi.org/10.1016/j.ijid.2023.09.006
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751